SCHEMBL16587446

SCHEMBL16587446

COCC(=O)c1nn(-c2ccccc2Cl)c(-c2noc(-c3cccc(S(C)(=O)=O)c3)n2)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 5/20 0.46
NR1H2 P55055 5/20 0.46
NR1H3 Q13133 5/20 0.46
CPT2 P23786 1/20 0.40
CPT1A P50416 1/20 0.40
S1PR1 P21453 1/20 0.40
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
SLC16A3 O15427 2/20 0.36
SLC16A1 P53985 1/20 0.36
MCTS1 Q9ULC4 1/20 0.36
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CNR1 P21554 2/20 0.35
TP53 P04637 2/20 0.34
NFKB1 P19838 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16587445 0.93 RXRA (0.46) RXRANR1H2NR1H3CPT2CPT1A
SCHEMBL16455621 0.89 RXRA (0.54) RXRANR1H2NR1H3CPT2CPT1A
SCHEMBL16587285 0.88 HAVCR2 (0.42) RAB9ANPC1SMN1; SMN2ALDH1A1CNR1
SCHEMBL16455248 0.88 NR1H2 (0.47) RXRANR1H2NR1H3CPT2CPT1A
SCHEMBL15242929 0.87 NR1H2 (0.46) RXRANR1H2NR1H3CPT2CPT1A
SCHEMBL16587444 0.84 NR1H2 (0.44) RXRANR1H2NR1H3CPT2CPT1A
SCHEMBL16455610 0.84 RXRA (0.53) RXRANR1H2NR1H3CPT2CPT1A
SCHEMBL16455283 0.83 RXRA (0.54) RXRANR1H2NR1H3S1PR1RAB9A
SCHEMBL16455252 0.82 NR1H2 (0.46) RXRANR1H2NR1H3CPT2CPT1A
SCHEMBL15242880 0.82 NR1H2 (0.46) RXRANR1H2NR1H3CPT2CPT1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8987318-B2 Liver X receptor (LXR) modulators for the treatment of dermal diseases, disorders and conditions ALEXAR THERAPEUTICS, INC. (US) 2015-03-24 US disclosed